The Closed-Loop Skincare System That's Leading the Industry
In an era where consumers demand both efficacy and safety from at-home skincare, Derminous has redefined the boundaries between clinical dermatology and daily self-care with its GeneLift™ Micro-Infusion System—a truly closed-loop skincare solution. Unlike traditional microneedling or topical serums that offer limited penetration, this system integrates a 24K gold-coated micro-infusion device, patented active ingredients, and a four-step ritual (Activate → Infuse → Soothe → Seal) to deliver professional-grade results without pain, downtime, or clinic visits[1] .






At the core of GeneLift™ lies a scientifically orchestrated synergy: PDRN (Polydeoxyribonucleotide) accelerates cellular repair[2] , acetyl hexapeptide-8 (marketed as Syn-Ake) mimics the wrinkle-smoothing effects of injectables[3] , and patented niacinamide formulations ensure brightening without irritation[4] . The 24K gold micro-needles—medical-grade stainless steel with antimicrobial properties—not only create transient microchannels for 3x deeper absorption but also minimize inflammation, making the system suitable even for sensitive or post-procedure skin.

What sets Derminous apart is its closed-loop design: every component—from serum to recovery mask to lifting cream—is engineered to work in sequence, ensuring no active ingredient is wasted and every step reinforces the next. This holistic approach aligns with the growing consumer shift toward “ritualized efficacy,” where skincare becomes both science and self-care[5] .

Clinical-inspired yet designed for home use, GeneLift™ bridges the gap once thought unbridgeable: real anti-aging transformation, without needles or compromise. As the global at-home aesthetic device market surges toward $12.7 billion by 2027[6] , Derminous isn’t just participating—it’s leading the paradigm shift.
Footnotes
Footnotes
-
Derminous Official Website – GeneLift™ System Overview. https://www.derminous.com/gene-lift-system↩
-
National Institutes of Health (NIH) – PDRn in Skin Regeneration. https://pubmed.ncbi.nlm.nih.gov/31537892/↩
-
Cosmetic Ingredient Review (CIR) – Acetyl Hexapeptide-8 Safety Assessment. https://www.cir-safety.org/ingredients/acetyl-hexapeptide-8↩
-
Chinese Patent Database – ZL2020116206743: Method for Controlling Nicotinic Acid in Niacinamide Production. http://epub.cnipa.gov.cn/↩
-
McKinsey & Company – The Future of Beauty: Ritual, Science, and Personalization (2024). https://www.mckinsey.com/industries/retail/our-insights/the-future-of-beauty↩
-
Grand View Research – At-Home Aesthetic Devices Market Size Report, 2023–2030. https://www.grandviewresearch.com/industry-analysis/at-home-aesthetic-devices-market↩





